Scholarlink

Background <p>Chronic kidney disease (CKD) carries the highest population attributable risk for mortality among all comorbidities in chronic heart failure (CHF). No studies about the association between inferior vena cava (IVC) diameter and all-cause mortality in patients with the comorbidity of CKD and CHF has been published.</p> Methods <p>In this retrospective cohort study, a total of 1327 patients with CHF and CKD were included. All patients underwent standardized echocardiography examination and data on demographic characteristics, medical history, and laboratory tests were recorded. Information on all-cause mortality was collected by telephone interview and medical records review. We used Cox regression to evaluate the risk of all-cause mortality among groups, and used mediation analysis to examine the mediation role of N-terminal-pro-B-type natriuretic peptide (NT-proBNP) and serum albumin in the association between IVC and all-cause mortality.</p> Results <p>During a median follow-up of 3.46&#xa0;years (IQR: 1.55–5.15&#xa0;years), 757 (57.05%) cases of all-cause mortality were observed. Compared with patients with IVC diameter &lt; 21&#xa0;mm, those with IVC diameter &gt; 21&#xa0;mm were associated with higher risk of all-cause mortality (HR (95%CI):1.31(1.07–1.61), log rank: <i>P</i> = 0.01) and cardiovascular mortality (HR (95%CI): 1.55(1.19–2.04), log rank: <i>P</i> = 0.001). When assessing IVC as a continuous variable, each 1% increase in IVC was associated with 4% increased risk of all-cause mortality (HR: 1.04, 95%CI 1.02–1.06, <i>P</i> &lt; 0.001). This association were mediated by log NT-proBNP (mediated effect: 37.8% (95%CI 22.0–73.0%), <i>P</i> &lt; 0.001) and serum albumin (mediated effect: 14.1% (95%CI 6.2–28.0%), <i>P</i> &lt; 0.001). In subgroup analyses, there was no significant interaction in different subgroups of cardiac and renal function for the association between IVC and all-cause mortality.</p> Conclusions <p>Elevated IVC diameter was associated with worse prognosis in patients with CHF and CKD, and the associations were mediated by log NT-proBNP and serum albumin.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Inferior vena cava diameter in patients with chronic heart failure and chronic kidney disease: a retrospective study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年1月15日

查看全文
  • Jianan Li,
  • Chi Wang,
  • Hui wu Dong,
  • Jing Qi,
  • Chongyou Rao,
  • Qiuyang Li,
  • Kunlun He

摘要

Background

Chronic kidney disease (CKD) carries the highest population attributable risk for mortality among all comorbidities in chronic heart failure (CHF). No studies about the association between inferior vena cava (IVC) diameter and all-cause mortality in patients with the comorbidity of CKD and CHF has been published.

Methods

In this retrospective cohort study, a total of 1327 patients with CHF and CKD were included. All patients underwent standardized echocardiography examination and data on demographic characteristics, medical history, and laboratory tests were recorded. Information on all-cause mortality was collected by telephone interview and medical records review. We used Cox regression to evaluate the risk of all-cause mortality among groups, and used mediation analysis to examine the mediation role of N-terminal-pro-B-type natriuretic peptide (NT-proBNP) and serum albumin in the association between IVC and all-cause mortality.

Results

During a median follow-up of 3.46 years (IQR: 1.55–5.15 years), 757 (57.05%) cases of all-cause mortality were observed. Compared with patients with IVC diameter < 21 mm, those with IVC diameter > 21 mm were associated with higher risk of all-cause mortality (HR (95%CI):1.31(1.07–1.61), log rank: P = 0.01) and cardiovascular mortality (HR (95%CI): 1.55(1.19–2.04), log rank: P = 0.001). When assessing IVC as a continuous variable, each 1% increase in IVC was associated with 4% increased risk of all-cause mortality (HR: 1.04, 95%CI 1.02–1.06, P < 0.001). This association were mediated by log NT-proBNP (mediated effect: 37.8% (95%CI 22.0–73.0%), P < 0.001) and serum albumin (mediated effect: 14.1% (95%CI 6.2–28.0%), P < 0.001). In subgroup analyses, there was no significant interaction in different subgroups of cardiac and renal function for the association between IVC and all-cause mortality.

Conclusions

Elevated IVC diameter was associated with worse prognosis in patients with CHF and CKD, and the associations were mediated by log NT-proBNP and serum albumin.